D-0601-2018 Class II Terminated

Recalled by Hetero Labs Limited Unit V — Jadcherla Mandal, Mahaboob Nagar

FDA drug recall D-0601-2018 was initiated by Hetero Labs Limited Unit V on Feb 13, 2018 and is designated Class II. Reason for recall: Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint… The recall status is terminated (terminated Feb 18, 2021). Affected quantity: 1764 60-count bottles.

Recall details

Product Type
Drugs
Report Date
Mar 21, 2018
Initiation Date
Feb 13, 2018
Termination Date
Feb 18, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1764 60-count bottles

Product description

Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60

Reason for recall

Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).

Distribution pattern

NJ and then distributed Nationwide in the USA

Code information

Lot #s VGC17040 & VGC17041, EXP 07/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0601-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0601-2018. Report a data issue: hello@regdatalab.com.